Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
Market Capitalization: 75.75 M
The data is delayed by 15 minutes.
CPIX is in the long-term down -18% below S&P in 4 years.
Description: Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on acquiring, developing, and commercializing branded prescription products for the hospital acute care and gastroenterology markets in the United States. The company?s principal products comprise Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. Its products also include Omeclamox-Pak, a triple therapy combination medication for the treatment of Helicobacter pylori infection and duodenal ulcer disease; and Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tenne
|Shares Outstanding||16.22 M||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-10.9%||Sales Growth - Q/Q||-6.88%||P/E|
|P/E To EPS Growth||P/S||2.02||P/BV||0.95||Price/Cash Per Share||1.43|
|Price/Free Cash Flow||11.6||ROA||2.37%||ROE||2.75%||ROI|
|Current Ratio||5.68||Quick Ratio||5.29||Long Term Debt/Equity||Debt Ratio||0.15|
|Gross Margin||86.23%||Operating Margin||8.41%||Net Profit Margin||5.82%||Dividend Payout Ratio|
|Cash From Financing Activities||-1.68 M||Cash From Investing Activities||-1.17 M||Cash From Operating Activities||2.03 M||Gross Profit||7.52 M|
|Net Profit||50 K||Operating Profit||Total Assets||92.19 M||Total Current Assets||67.55 M|
|Total Current Liabilities||11.89 M||Total Debt||Total Liabilities||12.82 M||Total Revenue||8.69 M|
|High 52 week||7||Low 52 week||4.73||Last close||5.53||Last change||-3.49%|
|RSI||53.94||Average true range||0.39||Beta||0.5||Volume||2.51 K|
|Simple moving average 20 days||-0.63%||Simple moving average 50 days||2.15%||Simple moving average 200 days||-4.66%|
|Performance Week||-4.49%||Performance Month||11.72%||Performance Quart||-1.78%||Performance Half||-8.6%|
|Performance Year||-0.9%||Performance Year-to-date||-8.29%||Volatility daily||3.24%||Volatility weekly||7.24%|
|Volatility monthly||14.85%||Volatility yearly||51.42%||Relative Volume||74.79%||Average Volume||33.67 K|
|New High||New Low|
2020-06-15 12:00:04 | All You Need to Know About Cumberland CPIX Rating Upgrade to Buy
2020-05-27 18:00:55 | Is Cumberland Pharmaceuticals CPIX A Good Stock To Buy Now?
2020-05-22 07:30:49 | Is Cumberland Pharmaceuticals Inc. NASDAQ:CPIX Excessively Paying Its CEO?
2020-05-20 18:15:10 | Cumberland Pharmaceuticals CPIX Q1 Earnings and Revenues Miss Estimates
2020-05-20 16:05:00 | Cumberland Pharmaceuticals Reports First Quarter 2020 Financial Results & Company Update
2020-05-20 14:30:00 | Cumberland Pharmaceuticals, Inc. to Host Earnings Call
2020-05-15 16:40:00 | Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results
2020-05-11 16:10:00 | Vibativ® Sustained Potency Confirmed In Two Surveillance Studies
2020-04-17 08:37:12 | Summit Therapeutics SMMT Catches Eye: Stock Jumps 8.9%
2020-04-16 08:37:12 | Ampio AMPE Looks Good: Stock Adds 5.2% in Session
2020-04-02 13:23:05 | LLY, OXM, AMAG, MIST and CPIX as Zacks Bull and Bear of the Day
2020-03-23 17:00:00 | Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections
2020-03-19 02:51:01 | Edited Transcript of CPIX earnings conference call or presentation 18-Mar-20 8:30pm GMT
2020-03-18 17:35:09 | Cumberland Pharmaceuticals CPIX Q4 Earnings and Revenues Beat Estimates
2020-03-18 16:05:00 | Cumberland Pharmaceuticals Reports 17% Revenue Growth For The Full Year 2019
2020-03-18 14:30:00 | Cumberland Pharmaceuticals, Inc. to Host Earnings Call
2020-03-17 09:35:00 | Caldolor® Demonstrates Favorable Safety Profile In Newborns
2020-03-11 12:30:04 | Earnings Preview: Cumberland Pharmaceuticals CPIX Q4 Earnings Expected to Decline
2020-03-06 16:35:00 | Cumberland Pharmaceuticals Reschedules Fourth Quarter And Annual 2019 Financial Results
2020-03-04 09:35:00 | Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2019 Financial Results
2020-01-02 09:35:00 | Cumberland Pharmaceuticals To Hold Update Call To Discuss Recent Major Developments
2019-12-22 18:43:58 | Cumberland Pharmaceuticals, Inc. CPIX: Hedge Funds In Wait-and-See Mode
2019-12-04 09:21:02 | New Strong Sell Stocks for December 4th
2019-12-02 08:00:00 | Cumberland Pharmaceuticals Receives FDA Approval for RediTrex™ Product Line
2019-11-29 18:31:09 | Edited Transcript of CPIX earnings conference call or presentation 12-Nov-19 9:30pm GMT
2019-11-25 09:35:00 | New Study Reveals Real-World Usage of Vibativ® In a Variety Of Infections
2019-11-12 16:05:00 | Cumberland Pharmaceuticals Reports 22% Revenue Growth In The Third Quarter
2019-11-05 17:45:10 | Cumberland Pharmaceuticals CPIX Dips More Than Broader Markets: What You Should Know
2019-11-05 11:24:04 | What's in Store for Cumberland Pharma CPIX in Q3 Earnings?
2019-11-05 09:35:00 | Cumberland Pharmaceuticals To Announce Third Quarter 2019 Financial Results
2019-11-02 10:30:11 | Is Cumberland Pharmaceuticals NASDAQ:CPIX Using Too Much Debt?
2019-10-30 17:45:09 | Cumberland Pharmaceuticals CPIX Outpaces Stock Market Gains: What You Should Know
2019-10-24 17:45:09 | Cumberland Pharmaceuticals CPIX Stock Sinks As Market Gains: What You Should Know
2019-10-16 17:50:09 | Cumberland Pharmaceuticals CPIX Dips More Than Broader Markets: What You Should Know
2019-10-10 17:45:09 | Cumberland Pharmaceuticals CPIX Outpaces Stock Market Gains: What You Should Know
2019-10-04 17:45:09 | Cumberland Pharmaceuticals CPIX Stock Sinks As Market Gains: What You Should Know
2019-09-26 11:01:03 | New Strong Buy Stocks for September 26th
2019-09-25 12:25:50 | Does Cumberland Pharmaceuticals Inc.'s NASDAQ:CPIX CEO Pay Matter?
2019-09-19 08:01:12 | New Strong Buy Stocks for September 19th
2019-09-13 09:25:01 | Cumberland Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy?
2019-09-12 10:26:02 | New Strong Buy Stocks for September 12th